CMS Should 'Clarify' Part B Inflation Rebates Don't Apply In Medicare Advantage, Pharma Says

Manufacturers ‘strongly object’ to the possibility floated by the Centers for Medicare and Medicaid Services that it could extend price inflation rebates to Part B drugs furnished to enrollees in Medicare Advantage plans in addition to those covered by fee-for-service Medicare.

CMS could apply price inflation rebates more broadly for Part B drugs. • Source: Shutterstock

More from Market Access

More from Pink Sheet